Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Pediatric super-refractory status epilepticus treated with allopregnanolone
Eileen Broomall1, JoAnne E Natale, Michele Grimason
1Ruth D. and Ken M. Davee Pediatric Neurocritical Care Program, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.
Insights
Super-refractory status epilepticus (SRSE) is a severe condition. Allopregnanolone successfully treated SRSE in two pediatric patients, resolving seizures and allowing anesthetic weaning.
Area of Science:
- Neuroscience
- Pediatric Neurology
- Pharmacology
Background:
- Super-refractory status epilepticus (SRSE) is a critical neurological emergency.
- Treatment resistance in SRSE is linked to synaptic GABAA receptor internalization.
- GABAA receptor dysfunction contributes to persistent seizures.
Observation:
- Two pediatric patients with SRSE were treated with the neurosteroid allopregnanolone.
- Allopregnanolone modulates GABAA receptors, acting as a positive allosteric modulator.
- This neurosteroid targets both synaptic and extrasynaptic GABAA receptors.
Findings:
- Allopregnanolone administration led to the resolution of status epilepticus in both pediatric cases.
- Patients were able to be weaned off general anesthetic infusions following treatment.
- This represents the first documented use of allopregnanolone for pediatric SRSE.
Implications:
- Allopregnanolone shows promise as a novel therapeutic agent for refractory epilepsy syndromes.
- Targeting GABAA receptors with neurosteroids may offer a new strategy for managing severe seizures.
- Further research is warranted to explore allopregnanolone's efficacy and safety in pediatric epilepsy.
Abstract:
Super-refractory status epilepticus is a life-threatening condition. Resistance to benzodiazepine and barbiturate treatment for this disorder is thought to be due to internalization of synaptic γ-aminobutyric acid (GABA)A receptors, and withdrawal of benzodiazepines and barbiturates during treatment often triggers seizure recurrence. The neurosteroid allopregnanolone acts as a positive allosteric modulator of synaptic and extrasynaptic GABAA receptors. Here we describe the use of allopregnanolone in 2 pediatric patients with super-refractory status epilepticus. This treatment allowed the general anesthetic infusions to be weaned with resolution of status epilepticus. This is the first report of allopregnanolone use to treat status epilepticus in children.
More Related Videos
08:43Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
Published on: July 21, 2015
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Parenteral Anesthetics: Overview
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Mania and Antimanic Drugs: Overview